威尔吉斯健康通过其人工智能中心推出实时保险验证,提高效率并将EBV定位为2026年关键的收入驱动力. Wellgistics Health launches real-time insurance verification via its AI hub, boosting efficiency and positioning EBV as a key 2026 revenue driver.

威尔吉斯健康 (WGRX) 已经为保险资格和福利验证 (EBV) 获得了优惠价格,通过其 EinsteinRx AI 枢纽,可实时检查患者和提供者的保险覆盖. Wellgistics Health (WGRX) has secured preferred pricing for insurance eligibility and benefits verification (EBV), enabling real-time coverage checks for patients and providers via its EinsteinRx AI hub. 现有这项服务支持药房查因TM平台,并与6 500多个药房和200多个制造商合并。 The service, now available, supports the PharmacyChain™ platform and integrates with over 6,500 pharmacies and 200+ manufacturers. EBV帮助减少索赔的拒绝和行政费用,该公司预期从2026年问题2开始,它将成为一个关键的收入来源。 EBV helps reduce claim denials and administrative costs, with the company expecting it to become a key revenue source starting in Q2 2026. 这一举动加强了Wellgistics更广泛的健康技术堆,支持数字处方路由,直接交付以及人工智能驱动的预先授权和遵守工具. The move strengthens Wellgistics’ broader health tech stack, supporting digital prescription routing, direct delivery, and AI-driven prior authorization and adherence tools. 预计EBV市场将从2025年的239亿美元增长到2030年的30亿美元,这是由于收费复杂性和数字健康的采用. The EBV market is projected to grow from $2.39 billion in 2025 to $3 billion by 2030, driven by billing complexity and digital health adoption.